Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
0.97/5.88
|
|
Enterprise Value
21.60B
|
| Balance Sheet |
|
Book Value Per Share
-1.52
|
| Cash Flow |
|
Cash Flow Yield
0.56
|
| Income Statement |
|
Total Revenue
823.72M
|
|
Operating Revenue Per Share
23.05
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reportsrevenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |

7.21 
